Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “DIABETES MELLITUS”

23,689 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 23,689 results

Post-approval studies (Phase 4)Looking for participantsNCT06291155
What this trial is testing

Mechanism of SGLT2 Inhibition in the Kidney

Who this might be right for
Type 2 DiabetesDiabetic Kidney Disease
University of Michigan 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT06866158
What this trial is testing

Autologous Dendritic Cell as Adjunct Therapy for Diabetic Kidney Disease

Who this might be right for
Diabetic Kidney Disease (DKD)
PT. JES Kasih Nusantara Sejahterah 80
Not applicableStudy completedNCT05822648
What this trial is testing

Evaluating a Type 2 Diabetes Prevention Program

Who this might be right for
Type 2 DiabetesPreDiabetes
Stanford University 62
Large-scale testing (Phase 3)Study completedNCT00101426
What this trial is testing

Safety and Efficacy of AS-3201 in the Treatment of Diabetic Sensorimotor Polyneuropathy

Who this might be right for
Diabetic Neuropathy
Sumitomo Pharma Co., Ltd. 500
Not applicableStudy completedNCT04757285
What this trial is testing

Copeptin and Psychological Stress of Medic During COVID-19 Pandemic

Who this might be right for
Psychological StressHemostatic Disorder
Alexandria University 90
Not applicableStudy completedNCT06187285
What this trial is testing

Efficay and Safety of Empagliflozin Versus Sitagliptin for the In-patient Management of Hyperglycemia

Who this might be right for
Type 2 Diabetes
Medanta, The Medicity, India 220
Not applicableStudy completedNCT05742685
What this trial is testing

Refinement and Adaption of Reinforcement Learning to Personalize Behavioral Messaging for Healthy Habits

Who this might be right for
Diabetes Mellitus, Type 2Medication Adherence
Brigham and Women's Hospital 28
Large-scale testing (Phase 3)Study completedNCT00325117
What this trial is testing

To Assess the Efficacy and Safety of Vildagliptin as Add-on Therapy to Sulfonylurea in Patients With Type 2 Diabetes Inadequately Controlled With Sulfonylurea Monotherapy

Who this might be right for
Diabetes Mellitus, Type 2
Novartis 200
Not applicableActive Not RecruitingNCT02276950
What this trial is testing

HeAlth-data Register sTudies of Risk and Outcomes in Cardiac Surgery

Who this might be right for
Cardiovascular DiseasesKidney DiseasesDepression+1 more
Ulrik Sartipy, MD, PhD 150,000
Not applicableActive Not RecruitingNCT06569290
What this trial is testing

Refinement and Testing of Recruitment Methodology for Behavioral Medication Adherence Interventions Using Behavioral Science-based Approaches

Who this might be right for
DiabetesPharmacist-Patient RelationsMedication Adherence
Brigham and Women's Hospital 590
Not applicableStudy completedNCT07269197
What this trial is testing

Association of SGLT2 Inhibitors Therapy With Elastographic and Molecular Markers of Liver Injury in Type 2 Diabetes

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseDiabetes Mellitus, Type 2
Josip Juraj Strossmayer University of Osijek 67
Not applicableStudy completedNCT00842010
What this trial is testing

Characteristics of Non Diabetic Hyperglycemic Inpatients

Who this might be right for
Diabetes Mellitus
Cook County Health 600
Testing effectiveness (Phase 2)Study completedNCT01930097
What this trial is testing

Closed-loop Control of Glucose Levels After Meal Intake in Adults With Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
Institut de Recherches Cliniques de Montreal 12
Post-approval studies (Phase 4)UnknownNCT04027023
What this trial is testing

Evaluation of the Impact of Intensive Short-Term Drug Therapy in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Sciema UG 9
Testing effectiveness (Phase 2)Study completedNCT00129259
What this trial is testing

Autoimmunity-blocking Antibody for Tolerance in Recently Diagnosed Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1
National Institute of Allergy and Infectious Diseases (NIAID) 83
Testing effectiveness (Phase 2)Study completedNCT01030679
What this trial is testing

Evaluate the Glycemic Control of CKD-501 in Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Chong Kun Dang Pharmaceutical 214
Early research (Phase 1)Study completedNCT01054118
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Doses of JNJ-38431055, Sitagliptin, and Co-administration of JNJ-38431055 and Sitagliptin

Who this might be right for
Diabetes Mellitus, Type 2
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 18
Post-approval studies (Phase 4)Study completedNCT02056210
What this trial is testing

Stem Cell Mobilization With Plerixafor in Diabetic vs Control Subjects

Who this might be right for
Diabetes
University of Padova 20
Not applicableStudy completedNCT07137013
What this trial is testing

Periodontitis Severity in Patients With Diabetic Retinopathy

Who this might be right for
Diabetic RetinopathyPeriodontitis
Recep Tayyip Erdogan University Training and Research Hospital 100
Not applicableUnknownNCT01178723
What this trial is testing

The Effects of Breakfast Size on Hormonal Profile in Adults With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Wolfson Medical Center 48
Load More Results